Potassium Chloride (KCl)

DRUG3 trials

Sponsors

University of Texas Southwestern Medical Center, University of Pennsylvania, Jens Titze

Conditions

Heart FailureHypertensionHypokalemiaPrimary Aldosteronism

Phase 2

Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)

CompletedNCT02840799

University of PennsylvaniaHeart Failure

Start: 2016-08-31End: 2022-08-31Updated: 2023-12-18

Unknown Phase

Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate

CompletedNCT02665117

University of Texas Southwestern Medical CenterHypertension

Start: 2015-01-31End: 2022-11-04Updated: 2023-10-25

Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

RecruitingNCT06569589

Jens TitzeHypertension, Hypokalemia, Primary Aldosteronism

Start: 2023-12-27End: 2026-08-31Target: 80Updated: 2025-06-06

Related Papers

MON-296 Tissue Sodium Content For Differential Diagnosis Of Essential Hypertension Versushyperaldosteronism: Baseline Characteristics Of The “See-Sodium-To-Treat (SSTT)” Trial

Journal of the Endocrine Society2025-10-01

Potassium Nitrate in Heart Failure With Preserved Ejection Fraction

JAMA Cardiology2024-12-189 citations

Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association2017-02-0244 citations